Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Optimize the Extent of Pulmonary Resection According to the Decision-Making Algorithm in Patients With Clinical Stage IA Non-Small Cell Lung Cancer

NCT03066297 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03066297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Optimize the Extent of Pulmonary Resection According to the Decision-Making Algorithm in Patients With Clinical Stage IA Non-Small Cell Lung Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
February 15, 2017
Completion date
February 15, 2027
Enrollment
1,018 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia non-small cell lung cancer